NCT06889571

Brief Summary

Study Goal The goal of this clinical trial is to evaluate whether a nurse-supported mobile app for self-help cognitive behavioral therapy for insomnia (CBT-I) is feasible for cancer caregivers and whether it can improve their sleep-related outcomes and overall well-being. Main Questions

  • These sessions may be conducted via phone calls or instant messaging, based on participant preference.
  • Each session includes reviewing weekly progress, addressing any barriers to adherence, and planning next steps.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 21, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2025

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

March 11, 2025

Last Update Submit

July 30, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Recruitment rate

    The recruitment rate will be evaluated by the percentage of the target number of participants successfully recruited per month.

    Every month, up to 1 year

  • Retention rate

    The retention rate will be assessed by the percentage of recruited participants providing outcome data at post-intervention time point.

    Post-intervention (i.e., at the end of the 6-week intervention period)

  • Adherence rate

    The adherence rate will be measured by the percentage of recruited participants who adhere to the proposed intervention, including reviewing sessions on the WeChat mini program and engaging in weekly nurse support sessions.

    Post-intervention (i.e., at the end of the 6-week intervention period)

  • Participants' perspectives of acceptability and satisfaction

    The participants' perspectives of acceptability and satisfaction will be evaluated using eight adapted items from the Acceptability E-scale. Each item is rated on a 5-point Likert scale, with scores ranging from 1 to 5. The total score ranges from 8 to 40, with higher scores indicating greater acceptability and satisfaction with the intervention.

    Post-intervention (i.e., at the end of the 6-week intervention period)

  • Adverse events

    All adverse events reported by the participants will be documented.

    Throughout the study period (from baseline to post-intervention [i.e., at the end of the 6-week intervention period])

  • Participants' perceived experiences of the proposed intervention

    Participants' perceived experiences of the proposed intervention (e.g., intervention delivery, adherence, safety, and satisfaction) will be assessed through post-intervention qualitative interviews to provide a further understanding of the intervention's feasibility.

    Post-intervention (i.e., at the end of the 6-week intervention period)

Secondary Outcomes (8)

  • Insomnia severity

    T0 (Baseline): prior to the start of the intervention, T1 (6 weeks): Post-intervention (i.e., at the end of the 6-week intervention period)

  • Sleep patterns

    T0 (Baseline): prior to the start of the intervention, T1 (6 weeks): Post-intervention (i.e., at the end of the 6-week intervention period)

  • Sleep quality

    T0 (Baseline): prior to the start of the intervention, T1 (6 weeks): Post-intervention (i.e., at the end of the 6-week intervention period)

  • Caregiver burden

    T0 (Baseline): prior to the start of the intervention, T1 (6 weeks): Post-intervention (i.e., at the end of the 6-week intervention period)

  • Depressive symptoms

    T0 (Baseline): prior to the start of the intervention, T1 (6 weeks): Post-intervention (i.e., at the end of the 6-week intervention period)

  • +3 more secondary outcomes

Study Arms (1)

Nurse-Supported Mobile App for Self-Help CBT-I in Cancer Caregivers

EXPERIMENTAL
Behavioral: Nurse-Supported Mobile App for Self-Help CBT-I

Interventions

The intervention consists of two components: 1) a mobile app delivered 6-week self-help CBT-I program; and 2) Weekly nurse support session.

Nurse-Supported Mobile App for Self-Help CBT-I in Cancer Caregivers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Informal caregiver (e.g., family members, friends, or neighbors) who co-resides with and provides unpaid care for cancer survivors of any site or stage, with daily contact of at least 4 hours. If two or more caregivers are available for a cancer survivor, the one providing most of the daily care will be included.
  • Able to understand the research procedures, and read and communicate in Chinese
  • Able to use WeChat
  • Insomnia severity index scores \> 7

You may not qualify if:

  • Another sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome, rapid eye movement behavior disorder), besides insomnia, that is not adequately treated
  • Psychotic disorders (e.g., bipolar disorder, schizophrenia); Suicidal ideation with intent and plan OR attempted suicide within the past 2 months
  • Currently taking any psychotropic drugs (e.g., antidepressants, anxiolytics, sleep medications)
  • Unstable or acute medical condition or condition requiring surgery in the next 6 months; Pregnancy; or Epilepsy
  • Currently participating in any other interventional program
  • Prior experience with CBT-I
  • Night, evening, early morning or rotating shift work
  • Currently caring for a cancer patient receiving hospice care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, China

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 11, 2025

First Posted

March 21, 2025

Study Start

May 12, 2025

Primary Completion

July 20, 2025

Study Completion

July 23, 2025

Last Updated

August 3, 2025

Record last verified: 2025-07

Locations